Article History
Received: 16 January 2024
Revised: 30 January 2024
Accepted: 12 February 2024
First Online: 24 February 2024
Competing interests
: EAJ is or has been consultant and/or paid speaker for Bayer, Ibsa, Menarini, Otsuka, Pfizer, Shionogi, and Viatris. The authors declare no competing interests.